Evidence map›Paper›PMID 26973285›Full record

ArticleJournal of virological methods2016

Real-time PCR for differential quantification of CVI988 vaccine virus and virulent strains of Marek's disease virus.

Susan J Baigent, Venugopal K Nair, Hervé Le Galludec

Abstract read
In one paragraph

Article in Journal of virological methods, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. TheViruses · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Susan J BaigentAvian Oncogenic Virus Group, The Pirbright Institute, Woking, GU24 0NF, United Kingdom. Electronic address: sue.baigent@outlook.com.
Venugopal K NairAvian Oncogenic Virus Group, The Pirbright Institute, Woking, GU24 0NF, United Kingdom. Electronic address: venugopal.nair@pirbright.ac.uk.
Hervé Le GalludecZoetis International Services, 23-25 Avenue du Docteur Lannelongue, 75668 Paris Cedex 14, France. Electronic address: Herve.Legalludec@zoetis.com.

Funding

Biotechnology and Biological Sciences Research Council
6 · The paper itself

Abstract

CVI988/Rispens vaccine, the 'gold standard' vaccine against Marek's disease in poultry, is not easily distinguishable from virulent strains of Marek's disease herpesvirus (MDV). Accurate differential measurement of CVI988 and virulent MDV is commercially important to confirm successful vaccination, to diagnose Marek's disease, and to investigate causes of vaccine failure. A real-time quantitative PCR assay to distinguish CVI988 and virulent MDV based on a consistent single nucleotide polymorphism in the pp38 gene, was developed, optimised and validated using common primers to amplify both viruses, but differential detection of PCR products using two short probes specific for either CVI988 or virulent MDV. Both probes showed perfect specificity for three commercial preparations of CVI988 and 12 virulent MDV strains. Validation against BAC-sequence-specific and US2-sequence-specific q-PCR, on spleen samples from experimental chickens co-infected with BAC-cloned pCVI988 and wild-type virulent MDV, demonstrated that CVI988 and virulent MDV could be quantified very accurately. The assay was then used to follow kinetics of replication of commercial CVI988 and virulent MDV in feather tips and blood of vaccinated and challenged experimental chickens. The assay is a great improvement in enabling accurate differential quantification of CVI988 and virulent MDV over a biologically relevant range of virus levels.

Indexed as

Real-Time Polymerase Chain ReactionAnimalsAntigens, ViralBase SequenceChickensDNA, ViralHerpesvirus 2, GallidMardivirusMarek DiseaseMarek Disease VaccinesPhosphoproteinsReproducibility of ResultsSensitivity and SpecificityAntigens, ViralDNA, ViralMarek Disease Vaccinesphosphoprotein pp38, Marek's disease virusPhosphoproteinsCVI988/RispensMarek’s disease viruspp38Real-time PCRSingle nucleotide polymorphismVaccination

Identifiers

PMID26973285
PMCPMC4850249

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.